Cancer immunotherapy utilizing gene-modified T cells: From the bench to the clinic
- 1 October 2015
- journal article
- review article
- Published by Elsevier in Molecular Immunology
- Vol. 67 (2) , 46-57
Abstract
No abstract availableKeywords
This publication has 161 references indexed in Scilit:
- Coordinated regulation of myeloid cells by tumoursNature Reviews Immunology, 2012
- A human memory T cell subset with stem cell–like propertiesNature Medicine, 2011
- T Cells Targeting Carcinoembryonic Antigen Can Mediate Regression of Metastatic Colorectal Cancer but Induce Severe Transient ColitisMolecular Therapy, 2011
- Primed tumor-reactive multifunctional CD62L+ human CD8+ T cells for immunotherapyCancer Immunology, Immunotherapy, 2010
- An Improved Bicistronic CD20/tCD34 Vector for Efficient Purification and In Vivo Depletion of Gene-Modified T Cells for Adoptive ImmunotherapyMolecular Therapy, 2010
- Engineering CD19-specific T lymphocytes with interleukin-15 and a suicide gene to enhance their anti-lymphoma/leukemia effects and safetyLeukemia, 2010
- Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2Molecular Therapy, 2010
- Chimeric Antigen Receptors Combining 4-1BB and CD28 Signaling Domains Augment PI3kinase/AKT/Bcl-XL Activation and CD8+ T Cell–mediated Tumor EradicationMolecular Therapy, 2010
- Single-pass, closed-system rapid expansion of lymphocyte cultures for adoptive cell therapyJournal of Immunological Methods, 2009
- Ocular and Systemic Autoimmunity after Successful Tumor-Infiltrating Lymphocyte Immunotherapy for Recurrent, Metastatic MelanomaOphthalmology, 2009